Elongation of the C-terminal domain of an anti-amyloid β single-chain variable fragment increases its thermodynamic stability and decreases its aggregation tendency

References

• Gouras GK. Immunotherapy for Alzheimer disease. MAbs 2009; 1:112 - 4; http://dx.doi.org/10.4161/mabs.1.2.7829; PMID: 20061820
   PubMed Web of Science ®Google Scholar
• Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, et al. Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to tau-based immunization strategies. Immunotherapy 2012; 4:213 - 38; http://dx.doi.org/10.2217/imt.11.170; PMID: 22339463
   PubMed Web of Science ®Google Scholar
• Delrieu J, Ousset PJ, Caillaud C, Vellas B. ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches. J Neurochem 2012; 120:Suppl 1 186 - 93; http://dx.doi.org/10.1111/j.1471-4159.2011.07458.x; PMID: 21883222
   PubMedGoogle Scholar
• Thomas K. Trials for Alzheimer’s drug halted after poor results. The New York Times 2012.
   Google Scholar
• Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, et al. 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer’s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol 2010; 9:363 - 72; http://dx.doi.org/10.1016/S1474-4422(10)70043-0; PMID: 20189881
   PubMed Web of Science ®Google Scholar
• Prince M, Bryce R, Ferri C. World Alzheimer Report. The benefits of early diagnosis and intervention. Alzheimer’s Disease International 2011. http://www.alz.co.uk/research/WorldAlzheimerReport2011.pdf.
   Google Scholar
• Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400:173 - 7; http://dx.doi.org/10.1038/22124; PMID: 10408445
   PubMed Web of Science ®Google Scholar
• Frenkel D, Solomon B, Benhar I. Modulation of Alzheimer’s beta-amyloid neurotoxicity by site-directed single-chain antibody. J Neuroimmunol 2000; 106:23 - 31; http://dx.doi.org/10.1016/S0165-5728(99)00232-5; PMID: 10814779
   PubMed Web of Science ®Google Scholar
• Fukuchi K, Accavitti-Loper MA, Kim HD, Tahara K, Cao Y, Lewis TL, et al. Amelioration of amyloid load by anti-Abeta single-chain antibody in Alzheimer mouse model. Biochem Biophys Res Commun 2006; 344:79 - 86; http://dx.doi.org/10.1016/j.bbrc.2006.03.145; PMID: 16630540
   PubMed Web of Science ®Google Scholar
• Zameer A, Kasturirangan S, Emadi S, Nimmagadda SV, Sierks MR. Anti-oligomeric Abeta single-chain variable domain antibody blocks Abeta-induced toxicity against human neuroblastoma cells. J Mol Biol 2008; 384:917 - 28; http://dx.doi.org/10.1016/j.jmb.2008.09.068; PMID: 18929576
   PubMed Web of Science ®Google Scholar
• Robert R, Dolezal O, Waddington L, Hattarki MK, Cappai R, Masters CL, et al. Engineered antibody intervention strategies for Alzheimer’s disease and related dementias by targeting amyloid and toxic oligomers. Protein Eng Des Sel 2009; 22:199 - 208; http://dx.doi.org/10.1093/protein/gzn052; PMID: 18927231
   PubMed Web of Science ®Google Scholar
• Pul R, Dodel R, Stangel M. Antibody-based therapy in Alzheimer’s disease. Expert Opin Biol Ther 2011; 11:343 - 57; http://dx.doi.org/10.1517/14712598.2011.552884; PMID: 21261567
   PubMed Web of Science ®Google Scholar
• Marín-Argany M, Rivera-Hernández G, Martí J, Villegas S. An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway. Biochem J 2011; 437:25 - 34; http://dx.doi.org/10.1042/BJ20101712; PMID: 21501114
   PubMed Web of Science ®Google Scholar
• Jacobson JS. Antibodies specific for epitopes within amyloid β (Aβ), for use in improving cognition. PCT Int Appl (2006), WO 2006066171 A1 20060622.
   Google Scholar
• Wisniewski T, Konietzko U. Amyloid-beta immunisation for Alzheimer’s disease. Lancet Neurol 2008; 7:805 - 11; http://dx.doi.org/10.1016/S1474-4422(08)70170-4; PMID: 18667360
   PubMed Web of Science ®Google Scholar
• Panza F, Frisardi V, Imbimbo BP, Seripa D, Paris F, Santamato A, et al. Anti-β-amyloid immunotherapy for Alzheimer’s disease: focus on bapineuzumab. Curr Alzheimer Res 2011; 8:808 - 17; http://dx.doi.org/10.2174/156720511798192718; PMID: 21592055
   PubMed Web of Science ®Google Scholar
• Villegas S, Rivera-Hernández G, Cervera L, Marín-Argany M, Blasco-Moreno B, Giménez-Llort L. Effects of scFv-h3D6 on 3xTg-AD mouse model of Alzheimer's disease: Cognitive improvement and modification of the Aβ-peptide aggregation pathway. 8th FENS 2012.
   Google Scholar
• Sreerama N, Manning MC, Powers ME, Zhang JX, Goldenberg DP, Woody RW. Tyrosine, phenylalanine, and disulfide contributions to the circular dichroism of proteins: circular dichroism spectra of wild-type and mutant bovine pancreatic trypsin inhibitor. Biochemistry 1999; 38:10814 - 22; http://dx.doi.org/10.1021/bi990516z; PMID: 10451378
   PubMed Web of Science ®Google Scholar
• Traxlmayr MW, Faissner M, Stadlmayr G, Hasenhindl C, Antes B, Rüker F, et al. Directed evolution of stabilized IgG1-Fc scaffolds by application of strong heat shock to libraries displayed on yeast. Biochim Biophys Acta 2012; 1824:542 - 9; http://dx.doi.org/10.1016/j.bbapap.2012.01.006; PMID: 22285845
   PubMed Web of Science ®Google Scholar
• Tsybovsky Y, Shubenok DV, Kravchuk ZI, Martsev SP. Folding of an antibody variable domain in two functional conformations in vitro: calorimetric and spectroscopic study of the anti-ferritin antibody VL domain. Protein Eng Des Sel 2007; 20:481 - 90; http://dx.doi.org/10.1093/protein/gzm034; PMID: 17962224
   PubMed Web of Science ®Google Scholar
• Baden EM, Owen BA, Peterson FC, Volkman BF, Ramirez-Alvarado M, Thompson JR. Altered dimer interface decreases stability in an amyloidogenic protein. J Biol Chem 2008; 283:15853 - 60; http://dx.doi.org/10.1074/jbc.M705347200; PMID: 18400753
   PubMed Web of Science ®Google Scholar
• Wörn A, Plückthun A. Different equilibrium stability behavior of ScFv fragments: identification, classification, and improvement by protein engineering. Biochemistry 1999; 38:8739 - 50; http://dx.doi.org/10.1021/bi9902079; PMID: 10393549
   PubMed Web of Science ®Google Scholar
• Schmid FX. Optical spectroscopy to characterize protein conformation and conformational changes. In: Creighton TE, ed. Protein Structure: A Practical Approach. 2ond ed.: IRL Press, Oxford University Press, 1997:261-267.
   Google Scholar
• Myers JK, Pace CN, Scholtz JM. Denaturant m values and heat capacity changes: relation to changes in accessible surface areas of protein unfolding. Protein Sci 1995; 4:2138 - 48; http://dx.doi.org/10.1002/pro.5560041020; PMID: 8535251
   PubMed Web of Science ®Google Scholar
• Wu TT, Kabat EA. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med 1970; 132:211 - 50; http://dx.doi.org/10.1084/jem.132.2.211; PMID: 5508247
   PubMed Web of Science ®Google Scholar
• Johnson G, Wu TT. Kabat Database and its applications: future directions. Nucleic Acids Res 2001; 29:205 - 6; http://dx.doi.org/10.1093/nar/29.1.205; PMID: 11125092
   PubMed Web of Science ®Google Scholar
• Wörn A, Plückthun A. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability. Biochemistry 1998; 37:13120 - 7; http://dx.doi.org/10.1021/bi980712q; PMID: 9748318
   PubMed Web of Science ®Google Scholar
• Ramm K, Gehrig P, Plückthun A. Removal of the conserved disulfide bridges from the scFv fragment of an antibody: effects on folding kinetics and aggregation. J Mol Biol 1999; 290:535 - 46; http://dx.doi.org/10.1006/jmbi.1999.2854; PMID: 10390351
   PubMed Web of Science ®Google Scholar
• Jäger M, Plückthun A. Domain interactions in antibody Fv and scFv fragments: effects on unfolding kinetics and equilibria. FEBS Lett 1999; 462:307 - 12; http://dx.doi.org/10.1016/S0014-5793(99)01532-X; PMID: 10622716
   PubMed Web of Science ®Google Scholar
• Kabat EA, Wu TT, Reid-Miller M, Perry H, Gottesman K, eds. Sequences of Proteins of Immunological Interest. Fourth Edition ed. US Govt. Printing Off. No. 165-492; 1987.
   Google Scholar
• Wörn A, Plückthun A. Stability engineering of antibody single-chain Fv fragments. J Mol Biol 2001; 305:989 - 1010; http://dx.doi.org/10.1006/jmbi.2000.4265; PMID: 11162109
   PubMed Web of Science ®Google Scholar
• Zandomeneghi G, Krebs MR, McCammon MG, Fändrich M. FTIR reveals structural differences between native beta-sheet proteins and amyloid fibrils. Protein Sci 2004; 13:3314 - 21; http://dx.doi.org/10.1110/ps.041024904; PMID: 15537750
   PubMed Web of Science ®Google Scholar
• Knappik A, Plückthun A. Engineered turns of a recombinant antibody improve its in vivo folding. Protein Eng 1995; 8:81 - 9; http://dx.doi.org/10.1093/protein/8.1.81; PMID: 7770457
   PubMedGoogle Scholar
• Pace CN, Scholtz M. In Protein structure, a practical approach (Creighton TE ed.), 1st edition. 1997:383.
   Google Scholar
• Pace CN. Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods Enzymol 1986; 131:266 - 80; http://dx.doi.org/10.1016/0076-6879(86)31045-0; PMID: 3773761
   PubMedGoogle Scholar
• Heinrikson RL. Applications of thermolysin in protein structural analysis. Methods Enzymol 1977; 47:175 - 89; http://dx.doi.org/10.1016/0076-6879(77)47022-8; PMID: 927174
   PubMedGoogle Scholar
• Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403 - 10; PMID: 2231712
   PubMed Web of Science ®Google Scholar
• Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993; 234:779 - 815; http://dx.doi.org/10.1006/jmbi.1993.1626; PMID: 8254673
   PubMed Web of Science ®Google Scholar
• Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 2007; 35:Web Server issue W407-10; http://dx.doi.org/10.1093/nar/gkm290; PMID: 17517781
   PubMedGoogle Scholar